Effects of bisphosphonates after denosumab discontinuation and treatment effect heterogeneity using causal machine learning
Abstract Discontinuation of denosumab is associated with a rebound increase in osteoporotic fracture (OF) risk, and bisphosphonates (BPs) are commonly recommended as sequential therapy to mitigate this risk. However, their real-world effectiveness—and whether certain patients benefit more than other...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Nature Portfolio
2025-12-01
|
| Σειρά: | Scientific Reports |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1038/s41598-025-28172-6 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
